IP Library › Assignment 046285/0488
Patent Assignment
Reel/Frame 046285/0488

Change of Name

Recorded: 2018-05-31 Pages: 3
Assignor
BIOGEN HEMOPHILIA INC.
Executed: 2016-09-01
Assignee
BIOVERATIV THERAPEUTICS INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Properties (3)
Factor IX Polypeptides and Methods of Use Thereof
Application: 15/820,080 →
Publication: US 2018/0207244
Factor IX Polypeptides and Methods of Use Thereof
Application: 15/890,284 →
Publication: US 2018/0228878
Factor IX Polypeptides and Methods of Use Thereof
Application: 15/890,290 →
Publication: US 2018/0228879
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 31, 2018
From: PIERCE, GLENN; TRUEX, SAMANTHA; PETERS, ROBERT T.; JANG, HAIYAN
To: BIOGEN IDEC HEMOPHILIA INC.
Reel/Frame 045955/0213 →
Change of Name May 31, 2018
From: BIOGEN IDEC HEMOPHILIA INC.
To: BIOGEN HEMOPHILIA INC.
Reel/Frame 046284/0835 →